GLP-1s may increase risk of osteoporosis and gout, new research finds
GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Surgeons’ annual meeting. Dr. John Horneff, an associate professor of orthopedic surgery at the University of Pennsylvania and the lead author of the study,…